The strategy for the control of anti-microbial resistance in Ireland, SARI, was launched in June 2001. Since then, approximately €16 million in funding has been made available by my Department to health boards under the strategy, of which approximately €4.5 million has been allocated in the current year. In addition, once-off funding of €565,000 was allocated in 2003 to fund special initiatives and measures recommended by the national SARI committee.
It is at the discretion of each health board CEO, in consultation with his or her respective regional SARI committee, to prioritise measures to be taken in his or her region to implement the recommendations of the SARI report. The amounts set out in the following table are net of the following non-pay inflators: 2002, 3.5%; 2003, 2.8%; and 2004, 2.8%.
|
Allocation
|
Board
|
2001
|
2002
|
2003
|
2004
|
|
€
|
€
|
€
|
€
|
ERHA
|
907,863
|
1,567,863
|
1,567,863
|
1,567,863
|
MHB
|
152,369
|
257,369
|
257,369
|
257,369
|
MWHB
|
215,855
|
375,855
|
375,855
|
375,855
|
NEHB
|
215,855
|
370,855
|
370,855
|
370,855
|
NWHB
|
146,020
|
253,020
|
253,020
|
253,020
|
SEHB
|
272,994
|
472,994
|
472,994
|
472,994
|
SHB
|
380,921
|
658,921
|
658,921
|
658,921
|
WHB
|
247,599
|
426,599
|
426,599
|
426,599
|
Total
|
2,539,476
|
4,383,476
|
4,383,476
|
4,383,476
|